Clinical trial: Who, what, where, why? | endTB

Skip to main content

Search

Main navigation

Our Work
Our Team
Countries
- Armenia
- Bangladesh
- Belarus
- DPRK
- Ethiopia
- Georgia
- Haiti
- India
- Indonesia
- Kazakhstan
- Kenya
- Kyrgyzstan
- Lesotho
- Myanmar
- Pakistan
- Peru
- South Africa
- Vietnam
Toolkit
News & stories
Resources

December 8, 2016

Teaser

Wondering what our clinical trial aims to achieve? Watch this MSF-produced video to find out more:

Latest news

Social workers connect patients with community organizations providing food, daily essentials, and counseling

August 12, 2022

Local Partners Key to Holistic TB Care in Kazakhstan

WHO rapid communication

endTB Statement on WHO Rapid Communication on key changes to the treatment of drug-resistant tuberculosis

Atul Loke/Panos Pictures

[Media] Ending TB by 2025 needs more clinical research on drug resistance

MDR-TB Treatment

GOOD SAFETY AND EFFICACY OF ANTI-TUBERCULOSIS TREATMENTS CONTAINING BEDAQUILINE OR DELAMANID, ADMINISTERED ALONE OR CONCOMITANTLY

Photos: Bithin Das / MDR-TB Treatment

October 18, 2021

Innovative Worldwide Clinical Trial for Multidrug-Resistant Tuberculosis Completes Enrollment

Photo Atul Loke/Panos Pictures

October 14, 2020

India: a new country for the endTB clinical trials

PIH

UNITAID

Footer menu

Contact
Sign in